BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 1940373)

  • 1. Staphylococcal toxins bind to different sites on HLA-DR.
    Chintagumpala MM; Mollick JA; Rich RR
    J Immunol; 1991 Dec; 147(11):3876-81. PubMed ID: 1940373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 bind to distinct sites on HLA-DR and HLA-DQ molecules.
    Scholl PR; Diez A; Geha RS
    J Immunol; 1989 Oct; 143(8):2583-8. PubMed ID: 2551962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of toxic shock syndrome toxin-1 to murine major histocompatibility complex class II molecules.
    Scholl PR; Sekaly RP; Diez A; Glimcher LH; Geha RS
    Eur J Immunol; 1990 Sep; 20(9):1911-6. PubMed ID: 2209697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of isotypes and allelic polymorphism on the binding of staphylococcal exotoxins to MHC class II molecules.
    Scholl PR; Diez A; Karr R; Sekaly RP; Trowsdale J; Geha RS
    J Immunol; 1990 Jan; 144(1):226-30. PubMed ID: 2404064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1.
    Karp DR; Teletski CL; Scholl P; Geha R; Long EO
    Nature; 1990 Aug; 346(6283):474-6. PubMed ID: 2377209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different staphylococcal enterotoxins bind preferentially to distinct major histocompatibility complex class II isotypes.
    Herrmann T; Accolla RS; MacDonald HR
    Eur J Immunol; 1989 Nov; 19(11):2171-4. PubMed ID: 2599004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1.
    von Bonin A; Ehrlich S; Malcherek G; Fleischer B
    Eur J Immunol; 1995 Oct; 25(10):2894-8. PubMed ID: 7589089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification from a phage display library of peptides that bind to toxic shock syndrome toxin-1 and that inhibit its binding to major histocompatibility complex (MHC) class II molecules.
    Sato A; Ida N; Fukuyama M; Miwa K; Kazami J; Nakamura H
    Biochemistry; 1996 Aug; 35(32):10441-7. PubMed ID: 8756700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of human T cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are HLA class II molecules.
    Uchiyama T; Imanishi K; Saito S; Araake M; Yan XJ; Fujikawa H; Igarashi H; Kato H; Obata F; Kashiwagi N
    Eur J Immunol; 1989 Oct; 19(10):1803-9. PubMed ID: 2583222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of Staphylococcus aureus exotoxin A inhibition of Ig production by human B cells.
    Moseley AB; Huston DP
    J Immunol; 1991 Feb; 146(3):826-32. PubMed ID: 1988499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR.
    Fraser JD
    Nature; 1989 May; 339(6221):221-3. PubMed ID: 2785644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcal enterotoxin D is a promiscuous superantigen offering multiple modes of interactions with the MHC class II receptors.
    Al-Daccak R; Mehindate K; Damdoumi F; Etongué-Mayer P; Nilsson H; Antonsson P; Sundström M; Dohlsten M; Sékaly RP; Mourad W
    J Immunol; 1998 Jan; 160(1):225-32. PubMed ID: 9551975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enterotoxin residues determining T-cell receptor V beta binding specificity.
    Irwin MJ; Hudson KR; Fraser JD; Gascoigne NR
    Nature; 1992 Oct; 359(6398):841-3. PubMed ID: 1436060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissection of the function of HLA class II and costimulation in B cell-mediated and toxic shock syndrome toxin-1-induced T cell proliferation.
    Dennig D; O'Reilly RJ
    J Immunol; 1993 Jun; 150(12):5231-40. PubMed ID: 7685791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of antigen-specific T cell activation by staphylococcal enterotoxins.
    Dowd JE; Jenkins RN; Karp DR
    J Immunol; 1995 Feb; 154(3):1024-31. PubMed ID: 7822779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of staphylococcal enterotoxin A to HLA-DR on B cell lines.
    Fischer H; Dohlsten M; Lindvall M; Sjögren HO; Carlsson R
    J Immunol; 1989 May; 142(9):3151-7. PubMed ID: 2785135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptors for toxic shock syndrome toxin-1 and staphylococcal enterotoxin A on human blood monocytes.
    See RH; Krystal G; Chow AW
    Can J Microbiol; 1992 Sep; 38(9):937-44. PubMed ID: 1281444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of binding domains on the superantigen, toxic shock syndrome-1, for class II MHC molecules.
    Soos JM; Russell JK; Jarpe MA; Pontzer CH; Johnson HM
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1211-7. PubMed ID: 8466498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. V alpha domain modulates the multiple topologies of mouse T cell receptor V beta20/staphylococcal enterotoxins A and E complexes.
    Bravo de Alba Y; Marche PN; Cazenave PA; Cloutier I; Sekaly RP; Thibodeau J
    Eur J Immunol; 1997 Jan; 27(1):92-9. PubMed ID: 9022003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human major histocompatibility complex class II-negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptor.
    Dohlsten M; Hedlund G; Segren S; Lando PA; Herrmann T; Kelly AP; Kalland T
    Eur J Immunol; 1991 May; 21(5):1229-33. PubMed ID: 1645269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.